On February 29th, join Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, for an informative look at what it takes to translate the results of an unbiased metabolomics discovery study into a robust analytical pipeline centered around a research-use-only, semi-quantitative LC-MS/MS methodology. Registration is complimentary. The webinar will be held twice—at 9:00 EST/14:00 GMT and 11:00 EST/16:00 GMT —giving you two opportunities to dialog with Dr. Tuytten.
Learn why it makes sense to employ multi-marker solutions for predicting pre-eclampsia, along with how Metabolomic Diagnositcs is developing a clinical research pipeline for assaying endogenous analytes. Learn how to optimize the use of Stable Isotope Labelled internal standards and other observations regarding the formulation of QC samples when working with bio-banked samples.
Dr. Tuytten will be available after both presentations to answer all participant questions.
Register for this complimentary webinar today.